___

• 1. Habermann, E., Bee and wasp venoms, The biochemistry and pharmacology of their peptides and enzymes are reviewed, Science, 177, 314-322, 1972.
• 2. Habermann, E., Reiz, K.G., Ein neues Verfahren zur Geqinjung der Komponenten von Bienengift, insbesondere des zentrtalwirsamen Peptide Apamin, Biochem, Z., 341, 451- 466,1965.
• 3. Habermann, E., Jontisch J., Sequential analysis of melittin from triptic and peptic fragments, Biochem Z., 348, 37-52, 1967.
• 4. Kreil, G., Kreil-Kiss, G., The isolation of N-formyl glycine from a polypeptide present in bee venom, Biochem, Biophys. Res, Comraun., 27, 275-280, 1967.
• 5. Orlov, B.N., Theoretical basis for therapeutical use of bee venom, Apiacta, 14, 12-15, 1979.
• 6. Orlov, B.N., Romanova, E.B., Omarov, S.M., Immunological properties of bee venom 28th Int. Congr. Apicult. Acapulco, Mexico, Apimondia Publishing House, Bucharest, 1981, pp 490-493.
• 7. Hait, W.N., Cadman, E., Benz, C„ Cole, J., Weiss, B., Inhibition of cyclic nucleotide phosphodiesterase and calmodulin. Proc. Am. Assoc. Cancer Res., 2, 5-7, 1983.
• 8. Hait, W.N., Lee, G.L., Characterization of the cytotoxic effects of calmodulin inhibitors, Clin. Res., 32, 416-419, 1984.
• 9. Hait, W.N., Grais, L., Benz, C., Cadman, E.C., Inhibition of growth of leukemic cells by inhibitors of calmodulin: phenothiazines and melittin, Cancer Chemother, Pharmacol., 14, 202-205, 1985.
• 10. Lee, G.L., Hait, W.N., Growth inhibition of C6 astrocytoma cells by inhibitions of calmodulin, Life Sciences, 36, 347- 354, 1985.
• 11. Okumara, K., Kato, T., Ito, J., Tanaka, R., Inhibition by calmodulin antagonists of glioblast DNA synthesis and morphological changes induced by glial maturation factor, Dev. Brain Res., 255, 661-665, 1982.
• 12. Means, A.R., Chafouleas, J.A., Lagace, L., Lai, E., Stein, JP., Multiple roles for calmodulin in the regulation of eukarryotic cell rtietabolism, Gene regulation, Academic, New York, pp 307-326, 1982.
• 13. Chafouleas, J.G., Bolton, W.E., Hidaka, H., Boyd, A.E., Means, A.R. Calmodulin and the cell cycle: involvement in regulation of cell cycle progression, Cell, 28, 41-50, 1982.
• 14. Tsuro, T., Iida, H„ Tsukagoshi, S., Sakurai, Y., Increased accumulation of vincristine and adriamycin in drug-resistant P388 tumor cells following with calcium antagonists and calmodulin inhibitors, Cancer Res., 42, 4730-4733, 1982.
• 15. Gamapathi, R., Grabowski, D., Enhancement of sensitivity to adriamycin in resistant P388 leukemia by the calmodulin inhibitor, trifluoperazine, Cancer Res., 43, 3696-3701, 1983.
• 16. Chafouleas, J.G., Botton, W.E., Means, A.R., Potentiation of bleomycin lethality by anti-calmodulin drugs: a role for calmodulin in DNA repair, Science, 224, 1346-1348, 1984.
• 17. Wei, J.W„ Hickie, R.A., Klaassen, D.J., Inhibition of human breast cancer colony formation by anticalmodulin agents, trifluoperazine, W-7 and W-13. Cancer Chemother, Pharmacol., 11, 86-90, 1983.
• 18. Ito, H., Hidaka, H., Antitumor effect of a calmodulin antagonist on the growth of solid sarcoma-180, Cancer Lett., 19, 215- 219, 1983.
• 19. Basic, I., Varga, E., Immunogenicity of mammary carcinoma and a fibrosarcoma of CBA mice, Period. Biol., 81, 335-337 1979.
• 20. Eljuga, Lj., Samija, M., Eljuga, D., Koşuta, D., Basic, I., Effect of rIL-2 and LAK cells on metastatic formation of an anaplastic carcinoma of the rat, Libri Oncol., 22, 177-181, 1993.
• 21. Milas, L., Hunter, N., and Withers, R.H., Corynebacterium granulosum induced against artificial pulmonary metastases of syngeneic fibrosarcoma in mice, Cancer Res., 34, 613-620, 1974.
• 22. Benton, A.W., Mors,e R.A., Stewart, J.B., Venom collection from honeybees, Science, 142, 228-230, 1963.
• 23. Mosman, T., Rapid colorimetric assay for cellular growth and survival: Apllication to proliferation and cytotoxicity assay, J. Immunol, Methods, 65, 55-63, 1983.
• 24. Telford, W.G., King, L.E., Fraker, P.J., Rapid quantitation of apoptosis in pure and heterogeneous cell populations using flow cytometry, J. Immunol. Method, 172, 1-16, 1994.
• 25. Sharma, V.S., Melittin resistance: a counterselection for ras transformation, Oncogene 7, 193-201, 1992.
• 26. Levin, R.M., Weiss, B., Mechanism by which psychotropic drugs inhibit adenosine cyclic 3,5-monophosphate phosphodiesterase of brain, Mol. Pharmacol., 12, 581-589, 1976.
• 27. Levin, R.M, Weiss, B., Binding of trifluoperazine on the calcium-dependent activator of cyclic nucleutide phosphodiesterase, Mol. Pharmacol., 13, 690-695, 1977.
• 28. Prozialeck, W.C, Weiss, B., Inhibition of calmodulin by phenothiazines and related drugs: structure-activity relationships, Pharmacol Exp. Ther., 222, 509-516, 1982.
• 29. Sellinger-Barnette, M., Weiss, B., Interaction of various peptides with calmodulin. In: Advances in cyclic nucleotide and protein phosphorylation research (Greengard and Robinson, eds), Raven, New York, pp. 261-276, 1984.
• 30. Townsed, G.F., Morgan, J.F., Hazlett, B„ Activity of 10- hydroxydecenoic acid from royal jelly against experimental leukemia and ascitic tumors, Nature, 183, 1270-1271, 1959.
• 31. Liu, X., Chen, D.W., Xie, L.P., Rongqing, Z„ Effect of honeybee venom on proliferation of K1735M2 mouse melanoma cells in-vitro and growth of murine B 16 melanomas in-vivo, J. Pharm. Pharmacol., 54, 1083-1089, 2002.
• 32. Tamura, T., Fujii, A., Kuboyama, N., Effects of royal jelly on experimental transplantable tumors, XXXth Int. Congr. Apicult. Nagoya, Apimondia Publishing House. Bucharest, pp 474-477, 1985.
• 33. Sver, L„ Orsolic, N., Tadic, Z., Njari, B., Valpotic, I., and Basic, I., A royal jelly as a new potential immunomodulator in rats and mice, Comp. Immun, Microbiol. Infect. Dis., 19, 31-38, 1996.
• 34. Killion, J.J., Dunn, J.D., Differential cytolysis of murine spleen, bone-marrow and leukemia cells by melittin reveals differences in membrane topography, Biochem. Biophys. Res. Commun, 139, 222-227, 1986.
• 35. Balk, S.D., Polimeni, P.I., Hoon, B.S., Le Stourgeon, D.N., Mitchell, R.S., Proliferation of Rous sarcoma virus-infected, but not of normal chicken fibroblasts in a medium of reduced calcium and magnesium concentration, Proc. Natl. Acad. Sci. USA, 76, 3913-3916, 1979.
• 36. Whitfield, J.F., Boynton, A.L., MacManus, J.P., Sicorska, M., Tsang, B.K., The regulation of cell proliferation by calcium and cyclic AMP. Mol. Cell Biochem., 27, 155-179, 1979.
• 37. Barnette, M.S., Daly, R., Weiss, B., Inhibition of calmodulin activity by insect venom peptides, Biochem Pharmacol 32, 2929-2933,1983.
• 38. Maulet, Y., Cox, J.A., Structural changes in melittin and calmodulin upon complex formation and their modulation by calcium, Biochem., 22, 5680-5685, 1983.
• 39. Comte, M., Maulet, Y., Cox, J.A., Ca2+ dependent high affinity complex formation between calmodulin and melittin, Biochem. 209, 269-273,1983. .
• 40. Tanaka, J., Takahashi, S„ Mitsui, Y., Itoh, S., Iitaka, Y., Kasai, H., Okuyama, T., X-Ray crystallographic and chromatographic characterization of the crystals of Ca2+- calmodulin complexed with bee venom mellittin, Mol. Biol., 186, 675-677, 1985.
• 41. Weiss, B., Wallace, T.L., Mechanism and pharmacological implications of altering calmodulin activity In: Calcium and cell function, Vol. 1. (Cheung WY, eds). Academic Press, New York. pp. 329-379, 1980.
• 42. Weiss B, Sellinger-Barnette M, Winkler JD, Schechter LE, Prozialeck WC: Calmodulin antagonists: strcture-activity relationships, In: Calmodulin Antagonists and Cellular Physiology (Hidaka H, Hartshorne D, eds) Academic Press, New York, pp 45-53, 1985.
• 43. Cheung, W.Y., Calmodulin: an overview, Fed. Proc., 41, 2253- 2257, 1982.
• 44. Kass, G.E.N., Duddy, S.K., Orrenius, S„ Activation of hepatocyte protein kinase C by redox - cycling quinones, Biochem. J., 260, 499-507, 1989 .
• 45. Zimmerman, T.P., Wolberg, G., Effect of calmodulin antagonists on lymphocyte-mediated cytolysis, Proc. Am. Assoc. Cancer Res., 25, 351-355, 1984.
• 46. Vaux, D.L., Strasser, A., The molecular biology of apoptosis, Proc. Natl. Acad. Sci. USA, 93, 2239-2244, 1996.
• 47. Orsolic N, Sver L, Bendelja K, Basic I., Antitumor activity of bee venom, Period. Biol., 103, 49-54, 2001.